कंपनी का अवलोकन
The Beauty Health Company operates as a global medical aesthetics firm that delivers an integrated ecosystem of clinically proven solutions across the Americas, Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. This entity functions within the Consumer Defensive sector and specifically the Household & Personal Products industry, providing stability through products that are essential to personal care routines regardless of broader economic cycles. The company maintains a market capitalization of $119.06M and generates annual revenue of $300.79M, while employing a workforce of 613 individuals to manage its extensive distribution network. These financial metrics indicate that the organization possesses a significant cash reserve relative to its market valuation, suggesting a capital-intensive structure typical of consumer goods firms where brand equity and operational scale are critical for maintaining market share.
वित्तीय स्वास्थ्य
The company reported a revenue of $300.79M over the trailing twelve months, yet it posted a net income of $-9,519,000, revealing a substantial gap that highlights a cost structure where operating expenses and other deductions significantly eroded profitability. Despite the negative net income, the firm generated an EBITDA of $4.55M, indicating that core operational cash generation remains positive even after accounting for depreciation and amortization. Crucially, the company produced free cash flow of $37.97M, which demonstrates strong financial flexibility to fund operations, repay debt, or invest in research without relying on external financing. The gross margin stands at 65.3%, reflecting high pricing power in the premium medical aesthetics product line, whereas the operating margin is a mere 0.2%, suggesting that overhead costs are aggressively consuming operating profits. The profit margin further deteriorates to -3.2%, confirming that the bottom line is currently under pressure from non-operating expenses or one-time charges. On the balance sheet, the company holds $230.67M in cash against total debt of $378.76M, resulting in a debt-to-equity ratio of 620.34, which indicates a highly leveraged position where debt obligations far exceed equity capitalization. Liquidity is supported by a current ratio of 1.66, meaning the company has sufficient short-term assets to cover its current liabilities, though the high leverage necessitates careful monitoring of cash burn. Return on Equity is -16.9% and Return on Assets is -2.2%, metrics that collectively reveal that management has not yet achieved effective capital allocation to generate returns on the shareholder's investment or the asset base in the current reporting period.
मूल्यांकन आकलन
The trailing P/E ratio is listed as N/A due to the negative earnings, while the forward P/E is 7.17, implying that the market is pricing in a significant turnaround in earnings expectations for the upcoming year. The price-to-book ratio is 1.95, suggesting that the stock trades at a premium of 95% above its tangible book value, which may reflect investor confidence in the brand's future intangible assets despite current losses. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.40 and an EV/EBITDA of 58.76, indicating that the market values the company based on sales multiples and enterprise value relative to earnings before interest, taxes, depreciation, and amortization rather than current profitability. The stock has fluctuated between a 52-week low of $0.76 and a 52-week high of $2.69, meaning the current trading price sits significantly below the recent peak, reflecting the volatility associated with its high debt load. The beta value is 1.24, indicating that the stock price exhibits higher volatility relative to the broader market, moving more aggressively than the index during periods of market stress or recovery.
Growth & Income
The revenue growth year-over-year is -1.4%, while earnings growth is N/A due to the negative net income, implying that the company is currently contracting rather than expanding its top line or profitability. Since the company does not pay a dividend, with a dividend yield of N/A and a payout ratio of 0.0%, all available earnings are theoretically available for reinvestment rather than distribution to shareholders. The absence of a dividend payout confirms that the company is currently retaining capital to address its debt obligations and improve its operating margins before considering shareholder returns. Overall, the growth and income profile is characterized by a contraction in revenue and a lack of current income distribution, requiring the market to rely entirely on potential future earnings recovery and the substantial existing cash reserves to drive value.